A Phase III Study of Entecavir vs Lamivudine in Chronic Hepatitis B Subjects With Incomplete Response to Lamivudine - Related Studies

A Phase III Study of Entecavir vs Lamivudine in Chronic Hepatitis B Subjects With Incomplete Response to Lamivudine

This study has been completed.

Study NCT00036608. Last updated on June 27, 2008. Information provided by Bristol-Myers Squibb

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Chronic Hepatitis B

2	Additional conditions recognized in this trial
		Hepatitis
		Hepatitis B
		Hepatitis B, Chronic
		Hepatitis, Chronic

3	More general conditions related to this trial
		Digestive System Diseases
		DNA Virus Infections
		Hepadnaviridae Infections
		Hepatitis, Viral, Human
		Liver Diseases
		Virus Diseases

4	Interventions listed in this trial
		Entecavir

5	More general drug interventions related to this trial
		Anti-Infective Agents
		Antiviral Agents
		Pharmacologic Actions
		Therapeutic Uses

6	Sponsors listed in this trial
		Bristol-Myers Squibb